首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4654篇
  免费   492篇
  国内免费   3篇
耳鼻咽喉   34篇
儿科学   173篇
妇产科学   61篇
基础医学   715篇
口腔科学   125篇
临床医学   561篇
内科学   857篇
皮肤病学   92篇
神经病学   587篇
特种医学   149篇
外科学   516篇
综合类   63篇
一般理论   2篇
预防医学   513篇
眼科学   38篇
药学   254篇
中国医学   1篇
肿瘤学   408篇
  2023年   45篇
  2022年   65篇
  2021年   126篇
  2020年   80篇
  2019年   139篇
  2018年   127篇
  2017年   106篇
  2016年   105篇
  2015年   121篇
  2014年   142篇
  2013年   219篇
  2012年   299篇
  2011年   285篇
  2010年   144篇
  2009年   124篇
  2008年   219篇
  2007年   197篇
  2006年   185篇
  2005年   171篇
  2004年   167篇
  2003年   163篇
  2002年   149篇
  2001年   99篇
  2000年   100篇
  1999年   120篇
  1998年   37篇
  1997年   44篇
  1996年   44篇
  1995年   38篇
  1994年   37篇
  1992年   78篇
  1991年   79篇
  1990年   60篇
  1989年   64篇
  1988年   53篇
  1987年   61篇
  1986年   53篇
  1985年   39篇
  1984年   53篇
  1983年   40篇
  1982年   42篇
  1981年   37篇
  1980年   29篇
  1979年   39篇
  1978年   41篇
  1977年   35篇
  1976年   32篇
  1975年   35篇
  1974年   34篇
  1973年   40篇
排序方式: 共有5149条查询结果,搜索用时 31 毫秒
51.
The U.S. Food and Drug Administration (FDA) terminated the use of ball clay from a mine in Mississippi as an additive in animal feed after discovering nanogram per gram concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD). The FDA collected chicken eggs and farm-raised catfish in affected areas and throughout the remaining continental United States to assess levels of 2,3,7,8-TCDD. A new method using quadrupole ion storage tandem-in-time mass spectrometry (QISTMS) measured the 2,3,7,8-TCDD levels in 42 catfish fillet composites, 3 Tilapia fillet composites, 46 chicken egg samples, and 6 chicken feeds. Six catfish composites and 20 egg samples had 2,3,7,8-TCDD concentrations significantly above 1.0 pg/g wet weight of fillet or whole egg. Farm-raised catfish not exposed to feed containing ball clay had a mean 2,3,7,8-TCDD concentration of 0.12 pg/g. The TCDD isomer pattern in ball clay differed from the TCDD isomer pattern in a fly ash sample and from the "chick edema factor" TCDD pattern in a sample of reference toxic fat used as a feed ingredient in the 1950s.  相似文献   
52.
53.
We report a case of symptomatic partial vascular ring that to our knowledge has not been previously described. This anomaly includes a right aortic arch with an aberrant left subclavian artery and an atypical origin of the right subclavian artery.  相似文献   
54.
Hayward LJ  Sandoval GM  Cannon SC 《Neurology》1999,52(7):1447-1453
OBJECTIVE: To evaluate the effects of missense mutations within the skeletal muscle sodium (Na) channel on slow inactivation (SI) in periodic paralysis and related myotonic disorders. BACKGROUND: Na channel mutations in hyperkalemic periodic paralysis and the nondystrophic myotonias interfere with the normally rapid inactivation of muscle Na currents following an action potential. This defect causes persistent inward Na currents that produce muscle depolarization, myotonia, or onset of weakness. Distinct from fast inactivation is the process called SI, which limits availability of Na channels on a time scale of seconds to minutes, thereby influencing muscle excitability. METHODS: Human Na channel cDNAs containing mutations associated with paralytic and nonparalytic phenotypes were transiently expressed in human embryonic kidney cells for whole-cell Na current recording. Extent of SI over a range of conditioning voltages (-120 to +20 mV) was defined as the fraction of Na current that failed to recover within 20 ms at - 100 mV. The time course of entry to SI at -30 mV was measured using a conditioning pulse duration of 20 ms to 60 seconds. Recovery from SI at -100 mV was assessed over 20 ms to 10 seconds. RESULTS: The two most common hyperkalemic periodic paralysis (HyperPP) mutations responsible for episodic attacks of weakness or paralysis, T704M and M1592V, showed clearly impaired SI, as we and others have observed previously for the rat homologs of these mutations. In addition, a new paralysis-associated mutant, I693T, with cold-induced weakness, exhibited a comparable defect in SI. However, SI remained intact for both the HyperPP/paramyotonia congenita (PMC) mutant, A1156T, and the nonparalytic potassium-aggravated myotonia (PAM) mutant, V1589M. CONCLUSIONS: SI is defective in a subset of mutant Na channels associated with episodic weakness (HyperPP or PMC) but remains intact for mutants studied so far that cause myotonia without weakness (PAM).  相似文献   
55.
56.
Three recombinant strains of Mycobacterium bovis Bacille Calmette Guerin (rBCG) were prepared in which the immunogenic B subunit of human Escherichia coli heat labile enterotoxin (LT-Bh) was expressed either as a cytoplasm protein, a cell wall associated lipoprotein or a secreted protein. Intraperitoneal immunisation of mice with these rBCG induced IgG and IgA antibodies to LT-Bh and shifted the serum IgG subclass response to subsequent challenge with purified LT-Bh from IgG1 to an IgG2a. Oral administration of recombinant BCG induced mucosal and serum IgA antibodies to LT-Bh which peaked four months after immunisation. Antibody responses were greater when LT-Bh was expressed as a secreted protein or lipoprotein rather than in the cytoplasm. Oral vaccination with recombinant BCG may be an effective approach, particularly to induce mucosal IgA and prime for a serum TH1 recall response.  相似文献   
57.
Clinical governance is being led by two people, usually a GP and a nurse, in most of the PCGs that responded to the survey. A fifth of the leads for clinical governance had no experience of working on quality issues. Nearly a third of respondents felt that their health authority had provided poor support or none at all. Only 10 PCGs had identified a clinical governance budget. No PCG was working with a finance manager to develop clinical governance and only five were working with an information manager.  相似文献   
58.

Objectives

To evaluate the efficacy of combined finasteride and flutamide therapy in men with advanced prostate cancer by determining (1 ) the short-term tolerability of finasteride monotherapy and its effect on serum prostate-specific antigen (PSA) and hormone (testosterone, dihydrotestosterone) levels, and (2) the effects of the addition of flutamide on tolerability and on serum PSA and hormone levels.

Methods

Thirteen hormone-naive men with advanced prostate cancer (4 with Stage D2, 1 with Stage D1, 1 with Stage DO, 7 with rising PSA levels after radical prostatectomy [n = 2]or definitive radiation therapy [n = 5]) were initially treated with 5 mg finasteride daily. Flutamide (250 mg three times a day) was added after serum PSA levels stabilized.

Results

Finasteride alone (median 5 weeks) had no significant effect on serum PSA levels (P>0.05). Combined finasteride and flutamide resulted in a mean 91% reduction in serum PSA levels, with 85% of men achieving a nadir serum PSA level of less than 4.0 ng/mL and 46% achieving undetectable levels (0.2 ng/mL or less). Finasteride alone had no significant effect on serum testosterone levels (P>0.05) but did result in a mean 74% reduction in serum dihydrotestosterone levels. Combined finasteride and flutamide resulted in a mean 56% increase in serum testosterone levels but had no additional effect on serum dihydrotestosterone levels (P>0.05). Side effects occurred in 85% (gynecomastia or breast tenderness in 62% [8 of 13]and diarrhea in 23% [3 of 13]) of men on combined therapy. Potency was preserved in 66%. Combined finasteride and flutamide therapy was withdrawn from 15% (2 of 13) because of flutamide-induced diarrhea and from 23% (3 of 13) because of disease progression. All remaining patients (8 of 13) have serum PSA levels below 4.0 ng/mL and 4 of these 8 have undetectable levels. These men have received combined finasteride and flutamide for a median 11 months (range 6 to 19).

Conclusions

Finasteride monotherapy is inadequate therapy for advanced prostate cancer, but combined finasteride and flutamide may be a reasonable alternative for men with advanced prostate cancer who refuse conventional hormone therapy.  相似文献   
59.
The use of a multimedia computer-based patient record (CPR) within ambulatory care is a topic that has not achieved widespread understanding or acceptance. However, if the topic is divided into its parts, multimedia and computer-based patient record, it reflects both highly recognizable and desirable goals that most health care organizations are undertaking. Multimedia technology is quickly maturing. In addition, the goal of attaining a CPR is of primary interest to most health care organizations. It is inevitable that these two technologies will eventually become synergistic. This article presents the case for a multimedia ambulatory CPR and describes one example of this happy marriage.  相似文献   
60.
    
Résumé Notre étude porte sur les toxicomanes en difficulté du fait de leur consommation de drogue dans le canton de Vaud; elle s'étend de 1974 à 1978 et bénéficie du concours de la police cantonale, d'hôpitaux, d'instituts médico-sociaux et de centres sociaux. L'observation porte sur 1519 cas de consommateurs de drogues dures, 1993 consommateurs de drogues douces et 186 cas d'abus chronique sévère de médicaments seuls.Pour les drogues dures, l'effectif annuel des cas nouveaux âgés de moins de 20 ans culmine en 1976. Quant aux «anciens» toxicomanes, leur effectif ne cesse d'augmenter. L'héroïne est la drogue la plus utilisée; elle est associée dans un quart des cas aux amphétamines, elles-mêmes remplacées par la cocaïne dès 1978. Les premières cohortes importantes d'héroïnomanes dans le canton de Vaud auront 28 à 30 ans en 1980.Pour les drogues douces, les effectifs enregistrés diminuent légèrement au cours des cinq ans d'observation. La participation des jeunes est particulièrement élevée, les anciens consommateurs sont beaucoup moins nombreux. L'usage de drogues dures ou douces concerne deux hommes pour une femme.L'abus sévère de médicaments touche un petit groupe plus âgé à prédominance féminine, qui varie peu au cours des cinq ans d'observation.
Drug-addiction in the canton of Vaud, 1974–8
Summary Our study is concerned with drug-addicts in the Swiss canton of Vaud who are in difficulties as a result of their drug consumption. The survey covers the period from 1974 until 1978, and was carried out with the assistance of the cantonal police, hospitals, sociomedical institutes, and social assistance centres. We investigated:1519 cases of consumers of hard drugs (opiates, amphetamines, and cocaine)1993 consumers of soft drugs (haschisch and hallucinogens)186 cases of serious chronic abuse of medicaments only, which were accidentally discovered by our information systemWith hard drugs, the annual number of new cases in the age group below 20 shows a peak in 1976, and remains so far at a level one third below. As far as older subjects are concerned, mostly old drug-addicts, the total number in the age group 20–29 continues to increase year after year. In exchange, in the age group 30 and older, the level of addiction to hard drugs remains constant and low. Heroin is drug number one, and is in 25 % of the cases associated with amphetamines, which are replaced by cocaine since 1977–8. It should be noted that the first bigger group of heroin-addicts in the canton of Vaud will be 28–30 years old in 1980. By the end of 1978, the total number of subjects addicted to hard drugs might amount to at least 830.The total number of subjects recorded as addicted to soft drugs decreased slightly in the course of the five years under observation. The percentage of young addicts is particularly high, while there are much fewer old consumers. Every third addict to hard or soft drugs is a woman.Abuse of medicaments is limited to a small group, which is older, consists predominantly of women, and varies little in the course of the five years under observation.The collected material is discussed in the light of data published in the foreign literature.

Drogenabhängigkeit im Kanton Waadt, 1974–1978
Zusammenfassung Unsere Untersuchung bezieht sich auf die Drogenabhängigen, welche zwischen 1974 und 1978 im Kanton Waadt durch ihren Drogenkonsum in Schwierigkeiten gekommen sind. Sie wurde ermöglicht durch die Mitwirkung der Kantonspolizei, von Spitälern, sozialmedizinischen Instituten und sozialen Einrichtungen. Folgende Gruppen von Drogenabhängigen wurden erfasst:1519 Konsumenten von harten Drogen (Opiate, Amphetamine, Kokain)1993 Konsumenten von weichen Drogen (Haschisch, Halluzinogene)186 Fälle von schwerem chronischem Medikamentenmissbrauch, welche zufällig durch unser Informationsnetz erfasst wurdenBei den harten Drogen erreicht die Anzahl der jährlichen neuen Fälle unter 20 Jahren 1976 den Höhepunkt und hält sich seither um einen Drittel unter diesem Niveau. Die Älteren sind meist schon Langzeitkonsumenten. Die Anzahl der 20- bis 29jährigen nimmt mit den Jahren ständig zu, die der 30jährigen und älteren bleibt gering und konstant. Heroin ist die meistgebrauchte harte Droge; in einem Viertel der Fälle wird es kombiniert mit Amphetaminen; diese werden seit 1977/78 durch Kokain ersetzt. Die ersten bedeutenden Kohorten von Heroinabhängigen im Kanton Waadt werden 1980 28 bis 30 Jahre alt sein. Die Gesamtzahl der Konsumenten von harten Drogen im Kanton Waadt dürfte Ende 1978 bei mindestens 830 liegen.Bei den weichen Drogen nimmt die Anzahl der registrierten Fälle im Laufe der fünf Jahre etwas ab. Der Anteil der Jungen ist hier besonders hoch. Langzeitkonsumenten sind hier weniger zahlreich. Der Konsum von harten und weichen Drogen betrifft doppelt so viele Männer wie Frauen.Schwerer Medikamentenmissbrauch wurde vor allem bei über 30jährigen angetroffen, vorwiegend bei Frauen. Im Laufe der fünf Jahre hat sich hier kaum etwas geändert.Die Angaben werden im Lichte der ausländischen Literatur diskutiert.
  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号